Skip to product information
1 of 1

Bortezomib-d8

Bortezomib-d8

Size

SKU:QM-0081861-01

£257.76 GBP
Sale Sold out
Quantity

Request quote or documents

View full details
  • Description

    Bortezomib-d8 is the deuterium labeled Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Bortezomib can be used for the study of multiple myeloma (MM) [1][2]. Bortezomib effectively inhibits TREM2 expression in tumor-associated macrophages (TAMs) [7].

  • Molecular Formula

    C19H17D8BN4O4

  • Molecular Weight

    392.29

  • Smiles

    OB([C@H](CC(C)C)NC(C(NC(C1=NC=CN=C1)=O)([2H])C([2H])([2H])C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])=O)O

  • Target

    Apoptosis; Autophagy; Isotope-Labeled Compounds; NF-κB; Proteasome; TREM receptor

  • Purity

    98

  • Solubility

    10 mM in DMSO|DMSO : 50mg/mL (ultrasonic) |Ethanol : 66.67mg/mL (ultrasonic; warming; heat to 60°C)

  • Storage Conditions

    -20°C (Powder, stored under nitrogen)

  • Shipping Conditions

    Blue Ice

Your cart
Variant Variant total Quantity Price Variant total
100 µgQM-0081861-01
100 µgQM-0081861-01
£257.76/ea
£0.00
£257.76/ea £0.00
1 mgQM-0081861-02
1 mgQM-0081861-02
£1,094.90/ea
£0.00
£1,094.90/ea £0.00

View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

Bortezomib-d8

Bortezomib-d8 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.